Assembly Biosciences Shares Soar Premarket on Gilead Pact
17 Oktober 2023 - 2:44PM
Dow Jones News
By Colin Kellaher
Shares of Assembly Biosciences more than doubled in premarket
trading Tuesday after the biotechnology company inked a
collaboration deal potentially worth hundreds of millions of
dollars with Gilead Sciences.
As part of the 12-year agreement, Assembly is receiving an
upfront payment of $100 million from Gilead, including $85 million
in cash and a $15 million equity investment at $1.16 a share, a 60%
premium to Monday's closing price of 72.6 cents.
The initial purchase gives Gilead a 19.9% stake in Assembly,
which had a market capitalization of about $37.4 million based on
Monday's closing price.
Assembly shares were recently up 130% to $1.67 in premarket
trading.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 17, 2023 08:29 ET (12:29 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Assembly Biosciences (NASDAQ:ASMB)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Assembly Biosciences (NASDAQ:ASMB)
Historical Stock Chart
Von Mai 2023 bis Mai 2024